Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Healthcare Equipment & Supplies Breadcrumb chevron Lucira Health Inc
Lucira Health Inc logo

LHDX - Lucira Health Inc Share News

$7 -0.1  -0.9%

Last Trade - 6:54pm

Sector
Healthcare
RiskRating
Highly Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap £195.3m
Enterprise Value £144.8m
Revenue £n/a
Position in Universe 4237th / 6852
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions LHDX Dividends
All News
All News Reuters News Company Announcements
BRIEF-FDA Authorizes First Single-Use, PCR Quality Over The Counter Lucira Check It Covid-19 At-Home Test
12th Apr News
BUZZ-U.S. STOCKS ON THE MOVE-Honeywell International, PriceSmart Inc and gold miners
9th Apr News
BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Alibaba Group, Bioceres, Tenax Therapeutics
9th Apr News
BUZZ-U.S. STOCKS ON THE MOVE-Celcuity Inc, Affimed, Sogou Inc, Lucira Health
9th Apr News
BUZZ-Lucira Health: Rises after COVID-19 test kit identifies variants
9th Apr News
BRIEF-Lucira Covid-19 Test Kit Identifies Viral Variants
9th Apr News
NASDAQ RESUMED AT 09:44 AM
8th Feb News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
8th Feb News
BUZZ-Immunocore Holdings: Jumps 58% in market debut on Nasdaq
5th Feb News
BUZZ-Lucira Health: Shares surge 30% on Nasdaq debut
5th Feb News
BRIEF-Lucira Health Shares Open 30% above IPO Price in NASDAQ debut
5th Feb News
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
5th Feb News
BRIEF-Lucira Health Prices Its Upsized IPO OF 9 Mln Common Shares At $17 Per Share
5th Feb News
BRIEF-Lucira Health Inc Sees IPO Of Up To 7.81 Mln Shares Of Common Stock Priced To Be Between $15 And $17 Per Share
1st Feb News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.